Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Southern National Bancorp Q2 EPS $0.42 Up From $0.19 YoY

Southern National Bancorp (NASDAQ:FRST) reported quarterly earnings of $0.42 per share. This is a 121.05 percent increase over earnings of $0.19 per share from the same period last year.

byBenzinga Newsdesk

July 29, 2021

1 minute read

Southern National Bancorp (NASDAQ:FRST) reported quarterly earnings of $0.42 per share. This is a 121.05 percent increase over earnings of $0.19 per share from the same period last year.

G2 Esports Partners With Herman Miller

By Benzinga Newsdesk

Today, 11:07 PM

https://news.millerknoll.com/2022-07-20-G2-Esports-Partners-With-Herman-Miller-to-Deliver-the-Ultimate-Gaming-Experience G2 Esports, one of the world’s most distinctive and successful esports and

MLKN

Barclays Maintains Equal-Weight on Hexcel, Raises Price Target to $67

By Benzinga Newsdesk

Today, 11:07 PM

Barclays maintains Hexcel (NYSE:HXL) with a Equal-Weight and raises the price target from $64 to $67.

HXL

Why Doximity Shares Are Trading Lower After Hours

By Akanksha Bakshi

Today, 11:07 PM

Doximity Inc (NYSE:DOCS) reported fourth-quarter revenue growth of 40.4% year-over-year to $93.7 million, beating the consensus of $90.11 million. Adjusted…

DOCS

Biora Therapeutics Presents Data From Device Performance Study With Repeat Doses In Both Fasted And Fed States At Crohn’s & Colitis Congress

By Benzinga Newsdesk

Today, 11:07 PM

Biora Therapeutics, Inc.

BIOR

Southern National Bancorp Q2 EPS $0.42 Up From $0.19 YoY

Related Posts

G2 Esports Partners With Herman Miller

Barclays Maintains Equal-Weight on Hexcel, Raises Price Target to $67

Why Doximity Shares Are Trading Lower After Hours

Biora Therapeutics Presents Data From Device Performance Study With Repeat Doses In Both Fasted And Fed States At Crohn’s & Colitis Congress